Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.3390/v13061120

http://scihub22266oqcxt.onion/10.3390/v13061120
suck pdf from google scholar
34200959!8230593!34200959
unlimited free pdf from europmc34200959    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid34200959      Viruses 2021 ; 13 (6): ä
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Discovery of Antivirals Using Phage Display #MMPMID34200959
  • Sokullu E; Gauthier MS; Coulombe B
  • Viruses 2021[Jun]; 13 (6): ä PMID34200959show ga
  • The latest coronavirus disease outbreak, COVID-19, has brought attention to viral infections which have posed serious health threats to humankind throughout history. The rapid global spread of COVID-19 is attributed to the increased human mobility of today's world, yet the threat of viral infections to global public health is expected to increase continuously in part due to increasing human-animal interface. Development of antiviral agents is crucial to combat both existing and novel viral infections. Recently, there is a growing interest in peptide/protein-based drug molecules. Antibodies are becoming especially predominant in the drug market. Indeed, in a remarkably short period, four antibody therapeutics were authorized for emergency use in COVID-19 treatment in the US, Russia, and India as of November 2020. Phage display has been one of the most widely used screening methods for peptide/antibody drug discovery. Several phage display-derived biologics are already in the market, and the expiration of intellectual property rights of phage-display antibody discovery platforms suggests an increment in antibody drugs in the near future. This review summarizes the most common phage display libraries used in antiviral discovery, highlights the approaches employed to enhance the antiviral potency of selected peptides/antibody fragments, and finally provides a discussion about the present status of the developed antivirals in clinic.
  • |*COVID-19 Drug Treatment[MESH]
  • |Antiviral Agents/*pharmacology[MESH]
  • |Cell Surface Display Techniques/*methods[MESH]
  • |Drug Discovery/*methods[MESH]
  • |Humans[MESH]
  • |Peptide Library[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box